HPV16 E6 TCR T Cells

· TCRCure Biopharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPV16 E6 TCR T Cells, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: HPV16 E6 TCR T Cells for Cervical Carcinoma [Phase 1, Phase 2]